Recurrent/Residual Intracranial Phosphaturic Mesenchymal Tumor Revealed on 68Ga-DOTATATE PET/CT.
暂无分享,去创建一个
[1] Fang Li,et al. The Findings on Bone Scintigraphy in Patients With Suspected Tumor-Induced Osteomalacia Should Not Be Overlooked , 2018, Clinical nuclear medicine.
[2] S. Basu,et al. 68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma. , 2016, Clinical nuclear medicine.
[3] H. Zhuang,et al. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia , 2015, Clinical nuclear medicine.
[4] U. Schüller,et al. Increased 68Ga-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue , 2015, The Journal of Nuclear Medicine.
[5] K. Herrmann,et al. Primary central nervous system lymphoma and meningioma in DOTATATE PET/CT. , 2013, Clinical nuclear medicine.
[6] H. Zhuang,et al. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan. , 2013, European journal of radiology.
[7] A. Folpe,et al. Intracranial phosphaturic mesenchymal tumors: report of 2 cases. , 2013, Journal of neurosurgery.
[8] A. Gill,et al. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. , 2013, The Journal of clinical endocrinology and metabolism.